Bladder Pain: The Patient Perspective

2017 ◽  
Vol 84 (1_suppl) ◽  
pp. 5-7 ◽  
Author(s):  
Jane M. Meijlink
Keyword(s):  
Quality Of Life ◽  
Chronic Pain ◽  
Urinary Tract ◽  
Patient Perspective ◽  
Pain Syndrome ◽  
Bladder Pain Syndrome ◽  
Bladder Pain ◽  
Practical Support ◽  
Tract Infections

Patients with chronic pain, discomfort and other urinary symptoms related to bladder pain syndrome or urinary tract infections may experience severely diminished quality of life and psychological and social problems, including depression, anxiety, and a sense of helplessness and hopelessness. These patients require empathy, understanding and practical support to allow them to cope with their chronic bladder disorder.

Improvements in patients’ quality of life following treatment with intravesical hyaluronic acid (Cystistat 40 mg) for bladder pain syndrome and recurrent UTIs

2020 ◽  
Vol 13 (2) ◽  
pp. 144-149
Author(s):  
Thomas D Brophy ◽  
Sue Fowler ◽  
Louise Clarke ◽  
Andy Thompson
Keyword(s):  
Quality Of Life ◽  
Urinary Tract ◽  
Urinary Tract Infections ◽  
Pain Syndrome ◽  
Bladder Pain Syndrome ◽  
Health Questionnaire ◽  
Bladder Pain ◽  
King’S Health Questionnaire ◽  
Tract Infections

Introduction: Intravesical hyaluronic acid (Cystistat) is indicated for a variety of chronic cystitis conditions including bladder pain syndrome, recurrent bacterial urinary tract infections and radiation or chemical cystitis. Previously published studies have predominantly assessed the outcome in terms of bladder symptoms (frequency/urgency/nocturia/pain) or in the case of recurrent bacterial urinary tract infection, by microbiological response. The aim of this study was to assess improvement in patients’ quality of life following treatment with intravesical Cystistat. Materials and methods: Patients’ referred for treatment with intravesical Cystistat for either bladder pain syndrome or recurrent bacterial urinary tract infection completed the King’s health questionnaire. Patients were treated with a 6-week course of Cystistat by one of two specialist urology nurses. If treatment was effective further instillations were given every 2–4 weeks for up to 6 months. King’s health questionnaire scores were repeated after 6 weeks and 6 months and were analysed. Results: Twenty patients (18 women, 2 men) were included: 8 bladder pain syndrome, 12 recurrent bacterial urinary tract infections. There were four treatment failures within 6 weeks, of whom three were being treated for recurrent bacterial urinary tract infections. Of the 16 patients who continued with treatment beyond 6 weeks, 12 have 6-month scores available. The average initial King’s health questionnaire score was 500.8 (534.1 for the recurrent bacterial urinary tract infection group, 450.8 for the bladder pain syndrome group). After six treatments average King’s health questionnaire scores improved to 426.3 (457.7 for recurrent bacterial urinary tract infections, 372.4 for bladder pain syndrome). After 6 months, average scores significantly improved to 278 overall (303.2 ( P<0.05) for the recurrent bacterial urinary tract infections group, 252.8 ( P>0.05) for the bladder pain syndrome group). Conclusion: Intravesical Cystistat should be considered in all patients with bladder pain syndrome and recurrent bacterial urinary tract infections. We have shown a significant, clinically important, improvement in patients’ quality of life in refractory bladder pain syndrome and recurrent bacterial urinary tract infections. In future Cystistat could be considered as an alternative to long-term low-dose antibiotic prophylaxis. Level of evidence: 4

scholarly journals Mirabegron to manage symptoms of interstitial cystitis / bladder pain syndrome: A stone for two birds?

2021 ◽  
pp. 020-023
Author(s):  
Pereira-Correia João Antonio ◽  
Nahoum Luiza Amaral ◽  
Aldred Pinto João Ernesto ◽  
Fernandes Muller Valter José
Keyword(s):  
Quality Of Life ◽  
Chronic Pain ◽  
Interstitial Cystitis ◽  
Pain Syndrome ◽  
Bladder Pain Syndrome ◽  
Urinary Urgency ◽  
Urinary Frequency ◽  
Bladder Pain ◽  
Pain Symptoms

Background: Interstitial Cystitis / Bladder Pain Syndrome (IC/BPS) patients often experience lowered quality of life due to pain, urinary urgency, and increases in urinary frequency. Like many chronic pain disorders, IC/BPS is poorly understood and treatment unsatisfactory. Materials and methods: We prospectively monitored the effects on pain and urinary complaints, of mirabegron associated with amitriptyline, for randomly selected women with IC/BPS. Results: Twenty-five women were randomly selected to treat pain symptoms of IC/BPS and 12 followed up until the end of the study. All patients showed improvement on all questionnaires referring to pain IC/BPS symptoms and urinary storage symptoms. There was no statistically significant improvement in urinary frequency. Conclusions: We suggest that mirabegron can work controlling urinary urgency and pain of IC/BPS patients.

scholarly journals Sleep Disturbances and Nocturnal Symptoms: Relationships with Quality of Life in a Population-Based Sample of Women with Interstitial Cystitis/Bladder Pain Syndrome

2014 ◽  
Vol 10 (12) ◽  
pp. 1331-1337 ◽  
Author(s):  
Wendy M. Troxel ◽  
Marika Booth ◽  
Daniel J. Buysse ◽  
Marc N. Elliott ◽  
Anne M. Suskind ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Interstitial Cystitis ◽  
Sleep Disturbances ◽  
Pain Syndrome ◽  
Population Based ◽  
Bladder Pain Syndrome ◽  
Bladder Pain

scholarly journals Validation of a quality-of-life scale for women with bladder pain syndrome/interstitial cystitis

2011 ◽  
Vol 21 (9) ◽  
pp. 1665-1670 ◽  
Author(s):  
Laura M. Bogart ◽  
Marika J. Suttorp ◽  
Marc N. Elliott ◽  
J. Quentin Clemens ◽  
Sandra H. Berry
Keyword(s):  
Quality Of Life ◽  
Interstitial Cystitis ◽  
Pain Syndrome ◽  
Bladder Pain Syndrome ◽  
Bladder Pain ◽  
Quality Of Life Scale ◽  
Life Scale

scholarly journals Addressing quality of life in the patient with interstitial cystitis/bladder pain syndrome

2017 ◽  
Vol 4 (1) ◽  
pp. 50-54 ◽  
Author(s):  
Vinaya Vasudevan ◽  
Robert Moldwin
Keyword(s):  
Quality Of Life ◽  
Interstitial Cystitis ◽  
Pain Syndrome ◽  
Bladder Pain Syndrome ◽  
Bladder Pain

Long-term follow-up after cystectomy for bladder pain syndrome: Pain status, sexual function and quality of life

2019 ◽  
Vol 18 (1) ◽  
pp. e1977
Author(s):  
L. Mateu Arrom ◽  
C. Gutierrez Ruiz ◽  
O. Mayordomo ◽  
V. Martínez ◽  
J. Palou ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Sexual Function ◽  
Pain Syndrome ◽  
Bladder Pain Syndrome ◽  
Bladder Pain ◽  
Pain Status ◽  
Long Term Follow Up

scholarly journals MP47-18 SIMPLE CYSTECTOMY FOR FEMALE PATIENTS WITH REFRACTORY INTERSTITIAL CYSTITIS/BLADDER PAIN SYNDROME: IS THERE ANY LONG-TERM IMPACT ON QUALITY OF LIFE, BODY IMAGE, AND SEXUAL FUNCTION?

2019 ◽  
Vol 201 (Supplement 4) ◽  
Author(s):  
Joao Zambon* ◽  
Kshipra Hemal ◽  
Robert Evans ◽  
Gopal Badlani ◽  
Steve Walker ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Body Image ◽  
Sexual Function ◽  
Interstitial Cystitis ◽  
Pain Syndrome ◽  
Bladder Pain Syndrome ◽  
Bladder Pain ◽  
Long Term Impact

Does Obtaining a Diagnosis of Interstitial Cystitis/Bladder Pain Syndrome Improve Symptoms or Quality of Life? A Cross-Sectional Questionnaire-Based Study

2020 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Katherine A. Volpe ◽  
Rachel Mandelbaum ◽  
Larissa V. Rodriguez ◽  
Begüm Z. Özel ◽  
Renee Rolston ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Interstitial Cystitis ◽  
Pain Syndrome ◽  
Bladder Pain Syndrome ◽  
Cross Sectional ◽  
Bladder Pain

Urology

2020 ◽  
pp. 83-110
Author(s):  
Helen Jefferis ◽  
Natalia Price
Keyword(s):  
Urinary Tract ◽  
Pain Syndrome ◽  
Bladder Pain Syndrome ◽  
Mechanism Of Injury ◽  
Bladder Pain ◽  
Ureteric Stenting ◽  
Investigation Methods ◽  
Vesicovaginal Fistulae ◽  
Injury And Repair ◽  
Tract Infections

This chapter covers various issues to do with urology in women. It begins by listing different investigation methods and what conditions they are best prepared to show. It then goes through various urological problems that may be encountered, such as ureteric stenting, haematuria, urinary tract infections and non-bacterial cystitis, and bladder pain syndrome. Urethral conditions and injuries to the urinary tract are both covered, including mechanism of injury and repair. Catheters, vesicovaginal fistulae, and urinary diversion are also described and given techniques for management.

Sign in / Sign up

Export Citation Format

Share Document